Physiologic Effects of Nasal High Flow on Exercise Tolerance in COPD
ConditionCOPD
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-100
SponsorUniversity of Miami
About this trial
This study aims to assess whether to describe the effects of the administration of nasal high flow (NHF) at 70 liters per minute (L/min) in a 6-Minute Walk Test (6-MWT) among Chronic Obstructive Pulmonary Disease (COPD) patients and to characterize the association between self-reported dyspnea with and without NHF at 70 L/min following a 6-MWT.
Eligibility criteria
Qualifiers
Able to consent
Age 18 years or older
Diagnosis of COPD
Ability to ambulate without assistance
Disqualifiers
Pregnancy
Being on bedrest
Inability to consent or cooperate with the study
Using of > 4 L/min of supplemental O2 or requiring non-invasive ventilation during the daytime
Trial design
Treatments tested in this trial
- Nasal High Flow Cannula
- Nasal Low Flow Cannula
Treatment groups
45 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Miami
Lead sponsor
American Thoracic Society
Collaborator
Source ClinicalTrials.gov